Question:
Does Medicare cover oral drugs that enhance the anti-neoplastic effect of the primary drug?
Answer:
According to the Medicare Benefit Policy Manual, “Oral drugs prescribed for use with the primary drug, which enhance the anti-neoplastic effect of the primary drug or permit the patient to tolerate the primary anti-neoplastic drug in higher doses for longer periods, are not covered.”